Author:
Soni Shruti,Maheshwari R. K.,Sah Abhishek K.
Publisher
Springer Science and Business Media LLC
Reference122 articles.
1. Homayun, B., Lin, X., & Choi, H.-J. (2019). Challenges and recent progress in oral drug delivery systems for biopharmaceuticals. Pharmaceutics, 11(3), 129.
2. Hua, S. (2020). Advances in oral drug delivery for regional targeting in the gastrointestinal tract - Influence of physiological, pathophysiological and pharmaceutical factors. Frontiers in Pharmacology, 11, 524. https://doi.org/10.3389/fphar.2020.00524
3. Sah, A. K., Vyas, A., Suresh, P. K., & Gidwani, B. (2018). Application of nanocarrier-based drug delivery system in treatment of oral cancer. Artificial Cells, Nanomedicine, and Biotechnology, 46(4), 650–657. https://doi.org/10.1080/21691401.2017.137328
4. Sahoo, D., Bandaru, R., Samal, S. K., Naik, R., Kumar, P., Kesharwani, P., et al. (2021). Oral drug delivery of nanomedicine. In S. Taurin & K. Greish (Eds.), Kesharwani P (pp. 181–207). Academic Press.
5. Rahman, M. A., Harwansh, R., Mirza, M. A., Hussain, S., & Hussain, A. (2011). Oral Lipid Based Drug Delivery System (LBDDS): Formulation, characterization and application: A review. Current Drug Delivery, 8(4), 330–345.